Physician
Anand Narayan MD INC
Anand Narayan MD INC was paid $6.05M by Medicaid between Jan 2018 and Dec 2021, across 51 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 89% of everything it billed.
33Billing provider infoANAND NARAYAN MD INC
DINUBA, CA 93618
DINUBA, CA 93618
33aNPI1427123496assigned 11/22/2006
33bProvider typeObstetrics & Gynecology Physician
28Total paid$6.05M
24GClaims111,127
24DCodes billed51
24AFirst – last monthJan 2018 – Dec 2021
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in California
Rank by total paid#18 of 791
Median peer was paid$67K
This provider vs. median91×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,106 | $1.44M | |
| 2019 | 31,757 | $1.50M | |
| 2020 | 27,681 | $1.51M | |
| 2021 | 22,583 | $1.59M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 89% | 73,070 | 62,808 | $5.36M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.4% | 18,726 | 15,237 | $386K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.0% | 2,336 | 2,069 | $61K |
| J3490 | Unclassified drugs | <1% | 481 | 469 | $33K |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 1,786 | 1,041 | $33K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,267 | 1,186 | $16K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 394 | 352 | $14K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 192 | 192 | $13K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 651 | 599 | $12K |
| 85018 | <1% | 1,513 | 1,502 | $9K | |
| 81025 | <1% | 797 | 744 | $9K | |
| 81003 | <1% | 1,416 | 1,372 | $8K |
39 more codes
| 90686 | <1% | 913 | $7K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 307 | $6K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 261 | $5K |
| 0064A | <1% | 100 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 400 | $5K |
| 99173 | <1% | 714 | $5K | |
| 86580 | <1% | 830 | $4K | |
| 0012A | <1% | 149 | $4K | |
| 92552 | <1% | 752 | $4K | |
| D1206 | Topical application of fluoride varnish | <1% | 470 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 257 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 184 | $3K |
| 0011A | <1% | 181 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 251 | $3K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 210 | $3K |
| 0072A | <1% | 48 | $3K | |
| 90700 | <1% | 179 | $2K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 158 | $2K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 268 | $2K |
| A4267 | Contraceptive supply, condom, male, each | <1% | 164 | $2K |
| 90670 | <1% | 172 | $2K | |
| 0071A | <1% | 30 | $2K | |
| 90648 | <1% | 184 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 104 | $1K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 121 | $1K |
| 90633 | <1% | 74 | $1K | |
| 90713 | <1% | 101 | $1K | |
| 90707 | <1% | 142 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 51 | $905.99 |
| 90716 | <1% | 140 | $863.80 | |
| 90723 | <1% | 78 | $595.98 | |
| 90715 | <1% | 28 | $559.69 | |
| 90680 | <1% | 84 | $471.96 | |
| 90734 | <1% | 67 | $258.60 | |
| 90620 | <1% | 17 | $254.94 | |
| 99000 | <1% | 28 | $197.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 211 | $146.10 |
| 90685 | <1% | 12 | $96.48 | |
| 90651 | <1% | 58 | $27.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNARAYAN, ANAND (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Anand Narayan MD INC | Dinuba, CA | $12.47M |
| Anand Narayan MD INC | Reedley, CA | $454K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.